Skip to main content
. 2017 Sep;9(9):E815–E826. doi: 10.21037/jtd.2017.08.54

Table 3. Antibody panel used in this case study.

Characteristic Glomus tumor Carcinoid tumor Hemangiopericytoma
SMA (+) (−) (−)
VIM (+) (−) (+)
CD34 (−) (−) (+)
CK (−) (+) (−)
Neuroendocrine (−) (+) (−)

SMA, smooth muscle actin; VIM, vimentin; CK, cytokeratin.